Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Status
Approved
Full Title
These highlights do not include all the information needed to use INSULIN GLARGINE-YFGN safely and effectively. See full prescribing information for INSULIN GLARGINE-YFGN. INSULIN GLARGINE-YFGN injection, for subcutaneous useInitial U.S. Approval: 2021This product is SEMGLEE (insulin glargine-yfgn). SEMGLEE (insulin glargine-yfgn) is interchangeable* with LANTUS (insulin glargine).
United States
Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.
